Preclinical mRNA vaccine shows promise against neuroblastoma, delaying tumour growth and reducing tumour burden Irish researchers have reported the first preclinical evidence that an mRNA vaccine can trigger an anti-tumour immune response against neurobla... See more
A new pilot study has found that fasting before and after chemotherapy sessions, when compared with regular eating, can help reduce insulin levels and may improve treatment response for women with high-grade serous ovarian cancer (HGSOC). The research was... See more
Results from the phase 3 PROTEUS study found that for people with localised high-risk prostate cancer, treatment with apalutamide and androgen deprivation therapy (ADT) along with surgery could delay or prevent worsening of the disease, with few additiona... See more
An artificial intelligence (AI)-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation. Researchers at Sylvester Co... See more
A real-world analysis of more than 10,000 patients with cancer found that GLP-1 receptor agonists (RAs) were associated with dramatically reduced metastatic progression across four different malignancies and independently improved overall survival in seve... See more
